Traditionally, stories include several key elements: characters, setting, plot and an inciting incident to catalyse the rest of the story through climax and resolution. Stories also have causality – ...
UCB’s Bimzelx (bimekizumab-bkzx) has been approved by the US Food and Drug Administration (FDA) to treat active moderate-to-severe hidradenitis suppurativa (HS) in adults. Estimated to affect one in ...
Patient pathways promise improved treatments and outcomes, yet they often lead to a maze of access, equity and service issues ...
GSK and Vesalius Therapeutics have entered into a strategic partnership worth $650m to discover and develop new treatments for Parkinson’s disease (PD) and one additional neurodegeneration indication.
From interactive case studies to AI-driven avatars, our free webinar dives into the tools defining tomorrow’s life sciences education. Last spots available – sign up now! Starting November 18, our ...
Merck KGaA and Abbisko Therapeutics have announced positive results from a late-stage study of pimicotinib in patients with ...
The explosive growth of Gen AI has caused plenty of consternation as well as celebration, but there’s no turning back the ...
Novartis and Schrödinger have entered into a research collaboration and licence agreement worth over $2.4bn to advance multiple drug candidates for Novartis to develop and commercialise. The alliance ...
AstraZeneca (AZ) and Merck – known as MSD outside the US and Canada – have shared positive results from a late-stage study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback